Akums Drugs & Pharmaceuticals Share Price

NSE
AKUMS •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Akums Drugs & Pharmaceuticals Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
49.73% Fall from 52W High
-30.6
TTM PE Ratio
Below industry Median
33.5
Price to Book Ratio
High in industry
12.9
Dividend yield 1yr %
0
TTM PEG Ratio

Akums Drugs & Pharmaceuticals Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Akums Drugs & Pharmaceuticals Ltd Quarterly Revenue

Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
1033.09 Cr
1019.11 Cr
944.21 Cr
1082.84 Cr
1181.25 Cr

Akums Drugs & Pharmaceuticals Ltd Yearly Revenue

Mar 2024Mar 2023Mar 2022
4212.21 Cr
3700.92 Cr
3694.52 Cr

Akums Drugs & Pharmaceuticals Ltd Quarterly Net Profit/Loss

Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
66.65 Cr
61.21 Cr
-39.47 Cr
195 Cr
32.69 Cr

Akums Drugs & Pharmaceuticals Ltd Yearly Net Profit/Loss

Mar 2024Mar 2023Mar 2022
0.79 Cr
98.02 Cr
-251.08 Cr

Akums Drugs & Pharmaceuticals Ltd shareholding Pattern

Promoter
75.3%
Foreign Institutions
7.3%
Mutual Funds
5.2%
Domestic Institutions
7.6%
Public
7.1%

Akums Drugs & Pharmaceuticals Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
5
Bearish Moving Averages
6
5Day EMA
574.80
10Day EMA
585.90
12Day EMA
590.40
20Day EMA
611.30
26Day EMA
628.70
50Day EMA
690.90
EMA
EMA
5Day SMA
573.50
10Day SMA
589.30
20Day SMA
607.20
30Day SMA
622.80
50Day SMA
722.60
SMA
SMA
SMA
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
311867 Rs
600765 Rs
Week Rs
155316 Rs
294139 Rs
Month Rs
242168 Rs
424838 Rs
Resistance & Support
571.68
Pivot
Resistance
First Resistance
591.02
Second Resistance
609.23
Third Resistance
628.57
Support
First Support
553.47
Second support
534.13
Third Support
515.92
Relative Strength Index
33.74
Money Flow Index
39.86
MACD
-38.29
MACD Signal
-41.60
Average True Range
26.70
Average Directional Index
38.30
Rate of Change (21)
-6.04
Rate of Change (125)
0.00

Akums Drugs & Pharmaceuticals Ltd Company background

Founded in: 2004
Managing director: SANDEEP JAIN
Akums Drugs and Pharmaceuticals Limited was incorporated vide Certificate of Incorporation dated April 19, 2004 and received a Certificate for Commencement of Business dated May 13, 2004 issued by the RoC.Alkums Drugs Pharmas are a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. They are into sale of branded pharmaceutical formulations and manufacturing of Active Pharmaceutical Ingredients. Some of the other services include formulation research and development, preparation and filing of regulatory dossiers into the Indian and global markets, and other testing services. Some of manufacturing units have been accredited by various global regulatory agencies such as the European Good Manufacturing Practice, the World Health Organization Good Manufacturing Practice and the United States National Sanitation Foundation. Their specialization extends to development and sale of APIs across diverse chemical processes and therapeutic areas such as antiinfective, respiratory and diabetes. In 2004, the Company established first plant for oral dosage commissioned at 19, 20, 21, Sector 6A, Haridwar, Uttarakhand. In 2007, it established dedicated manufacturing site for oral liquid dosage and sterile products both at Haridwar, Uttarakhand. It incorporated Maxcure Nutravedics Limited to venture into nutraceuticals in 2009. In 2010, it dedicated a facility for hormones dedicated a facility for cosmetics and dermatology at Haridwar, Uttarakhand. In 2010, it incorporated Akumentis Healthcare Limited to venture into branded formulations.In 2011, it innovated bilayered sustained release tablets for the first time. In 2012, acquired subsidiary, Pure and Cure Healthcare Private Limited to expand capacity and capabilities. In 2013, it acquired Malik Lifesciences Private Limited manufacturing sites to expand capacity and capabilities. It established RD Laboratory in Mumbai, Maharashtra to venture into regulated market in 2015. In 2021, the Company acquired Parabolic Drugs to form Akums Lifesciences Limited and ventured into APIs. Further, it acquired Kotdwar Plant in Uttarakhand by Akums Healthcare Limited. In 2022, it acquired facility in Haridwar, Uttarakhand through the subsidiaries, Akums Healthcare Limited and in 2023, acquired Baddi facility in, Himachal Pradesh through Pure and Cure Healthcare Private LimitedFollowing a Scheme of Arrangement on October 17, 2023, Akums Lifesciences Limited got merged with its subsidiary, Pure and Cure Healthcare Private Limited (PCHL) with effect from April 1, 2022. As part of this acquisition, it acquired manufacturing units in Dera Bassi and Lalru in Punjab and Barwala in Haryana, and an RD centre in Barwala, Haryana and commenced operations in the manufacture and sale of key starting materials, intermediates and APIs. The Company is proposing the Public Issue by raising funds aggregating Rs 680 Crores through Fresh Issue and by issuing 18,598,365 Equity Shares through Offer for Sale.
Read More

Akums Drugs & Pharmaceuticals Ltd FAQs

Akums Drugs & Pharmaceuticals Ltd shares are currently priced at 591.1 on NSE and 592.45 on BSE as of 12/20/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Akums Drugs & Pharmaceuticals Ltd [AKUMS] share was 0. The Akums Drugs & Pharmaceuticals Ltd [AKUMS] share hit a 1-year low of Rs. 530.05 and a 1-year high of Rs. 1175.9.

The market cap of Akums Drugs & Pharmaceuticals Ltd is Rs. 9015.53 Cr. as of 12/20/2024 12:00:00 AM.

The PE ratios of Akums Drugs & Pharmaceuticals Ltd is 139.11 as of 12/20/2024 12:00:00 AM.

The PB ratios of Akums Drugs & Pharmaceuticals Ltd is 4.03 as of 12/20/2024 12:00:00 AM

The Mutual Fund Shareholding was 5.18% at the end of 12/20/2024 12:00:00 AM.

You can easily buy Akums Drugs & Pharmaceuticals Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -